Hinge Health, Inc. (HNGE) shares tumbled 5.5% to $99.16 as of October 16, 2026, a significant decline from the prior close of $104.96. BestStocks flagged the session as a major change for HNGE. The move is tied to price move down. Below, we break down what changed for HNGE, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
What happened
HNGE fell 5.5% to $99.16
HNGE moved -6.92% from its $106.53 open to a $99.16 close on 2026-10-16. Monitor next session.
This summary describes the catalyst and move as first detected on Oct 16, 2026, 4:43 PM EDT; the stock has continued trading since, so the current price and percentage move (shown above) may be larger or smaller than the figures here.
Material / EarningsLow confidence
Rel. volume
0.9×
Below Avg
Vs peers
—
No comparable peers
Market cap
$8.0B
New York Stock Exchange
Analyst target
$103
+3.6% vs price
Price chart
Sep 15 – Oct 16
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details
What it means for Hinge Health, Inc. investors
For Hinge Health, Inc. investors, the recent signals add up to a bearish shift. On the constructive side: Hinge Health, Inc. (HNGE) moved +11.13% from $80.38 to $89.33 on 2026-08-07; Hinge Health, Inc. (HNGE) moved +5.66% from $76.46 to $80.79 on 2026-08-05. Weighing against that: Material negative event; Sharp 5.5% decline — elevated risk. Wall Street's consensus price target sits at $102.77, implying +3.6% upside from $99.16. BestStocks rates the overall signal quality low (57/100). With earnings roughly 17 days out, the next report is the most likely near-term test of the move.
HNGE price reaction
HNGE last traded at $99.16, down $5.80 (-5.53%) from the previous close of $104.96. The session traded on 0.9× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $91.98 and $105.14, and it currently sits about 55% of the way up that band.
Bullish and bearish analyst opinions on Hinge Health, Inc. (HNGE)
▼Latest catalyst·strengthens the bear case
The latest catalyst — a materially negative development — it strengthens the bear case.
The consensus analyst price target on Hinge Health, Inc. (HNGE) is $102.77, 3.6% above the recent $99.16. Over the past 90 days analysts logged 0 upgrades, 15 maintains, and 0 downgrades. Here is how the bullish and bearish cases on HNGE line up.
▲ The bullish case
+Wall Street's consensus price target of $102.77 implies +3.6% upside from $99.16.
+The Street's most bullish target is $140.00 (+41.2%).
+Hinge Health, Inc. (HNGE) moved +11.13% from $80.38 to $89.33 on 2026-08-07.
+Positive price momentum.
▼ The bearish case
−The most bearish analyst target is $76.00 (-23.4%).
−Material negative event.
−Sharp 5.5% decline — elevated risk.
−Hinge Health, Inc. (HNGE) moved -6.25% from $84.35 to $79.08 on 2026-07-22.
Bull vs bear balanceBearish Shift
BearishNeutralBullish
Weighing both sides, BestStocks' composite read of recent signals is bearish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Oct 16, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Hinge Health, Inc. (HNGE) moved +2.47% from $102.29 to $104.82 on 2026-10-12. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The stock reached a new 30-day high on below-average volume (0.6x the 5-day average).
News2026-10-08+0.1%
CEO Daniel Perez sold 4,100 HNGE shares at $100.20 per share for $410,820.
News2026-10-05+0.7%
Argent Capital Management LLC acquired 34,721 shares of HNGE in a new institutional investment position.
News2026-10-01+0.7%
HNGE stock reached a new 52-week high of $97.95 during mid-day trading Tuesday.
Hinge Health rose 2.88% to $97.95 following fresh analyst coverage initiation and price-target raises. BofA Securities initiated coverage with a Buy rating and $110 price target, while Needham & Company raised its target from $97.00 to $115.00 (investing.com). Analysts cited the digital physical therapy provider's ~50% top-line growth, 85%+ gross margins, and expanding free cash flow as drivers of confidence. Trading volume of 491,574 shares was below average at 0.49x expected for this stage of the session.
Material / Earnings2026-09-14+7.0%
Hinge Health, Inc. (HNGE) moved +6.88% from $88.69 to $94.79 on 2026-09-14, extending a multi-week rally. The move reflects strong Q2 2026 results—revenue jumped 53% year-over-year to $212.8 million with raised full-year guidance—plus expansion into Migraine Care and gastrointestinal care through Cylinder Health, and recent analyst price target upgrades supporting confidence in the company's AI-powered platform.
Material / Earnings2026-08-31+6.0%
Hinge Health, Inc. (HNGE) moved +6.54% from $86.88 to $92.56 on August 31, 2026. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume remained near its 5-day average.
Material / Earnings2026-08-28-5.9%
Hinge Health, Inc. (HNGE) moved -5.05% from $92.00 to $87.35 on 2026-08-28. We checked news, earnings, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume remained near its 5-day average at 1.1x, suggesting the move was not driven by unusual trading activity.
Upcoming catalysts & outlook
Next earnings
2026-11-02 (est.)
in 17 days
10-Q Filing (est.)
2026-11-05
Medium impact
Thesis shift
Bearish Shift
bearish signal
Risk level
Medium
from change events
Frequently asked questions about HNGE
Why did Hinge Health, Inc. (HNGE) stock move?
HNGE tumbled 5.5% to $99.16. The move is associated with price move down.
How much did HNGE stock fall?
HNGE lost 5.53% ($5.80) versus the prior close of $104.96, last trading at $99.16 on 0.9× average volume.
When is Hinge Health, Inc.'s next earnings date?
HNGE's next earnings report is estimated for 2026-11-02 — about 17 days away.
What is the analyst price target for HNGE?
The consensus analyst price target for HNGE is $102.77, about 3.6% above the current $99.16. Over the past 90 days, analysts recorded 0 upgrades, 15 maintains, and 0 downgrades.
How BestStocks tracks HNGE
This page is generated automatically by BestStocks' change-detection system after price move down was detected and verified against independent data sources. It draws on 20 tracked change events for HNGE, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of October 16, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.
